Will McLean, PhD
Co-founder, VP, Biology and Regenerative Medicine
Will, an expert in stem cell biology, hearing and neuroscience, leads scientific strategy at Frequency. Prior to co-founding Frequency, Will served as a scientific advisor for health sciences and venture funding firms, including Entrega Bio and Third Rock Ventures.
During his doctoral research at MIT, Will elucidated the different stem cell types that exist within the inner ear. He completed his post-doctoral studies at Harvard Medical School. Will’s research has been published in multiple peer reviewed journals, including the Journal of the Association for Research in Otolaryngology, Development, PLOS ONE, and Audiology Today.
He was awarded the Harvard-MIT IDEA2 award for high-impact translational research and was an MIT $100K finalist. Will has also been named to the MIT Technology Review 35, the 35 innovators under 35 most likely to impact technology, and the Hartford Business Journal 40 under 40. Will earned a Ph.D. from the Harvard-MIT Health Science and Technology Program within MIT and a B.S. in Biology from Tufts University.